Follow the 제노레이 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 제노레이 has recorded 38 public disclosures. Market capitalisation: €43.2bn. The latest transaction was disclosed on 27 May 2026 (Other). Among the most active insiders: 박병욱. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
€10,111
28 ops.
Buy Volume
€45,054
2 ops.
Sell Volume
22Σ signal
Buys €10,111€45,054 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,797 of 29,062 companies
49.6
score / 100
Value
63
Quality
37
FCF yld9.1%
Earn yld1.8%
EV/EBITDA9.0x
ROE3.2%
Gross mgn39%
Net mgn0.7%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Genorey es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en el desarrollo y la comercialización de productos farmacéuticos innovadores.